Commonwealth Equity Services, LLC Lexicon Pharmaceuticals, Inc. Transaction History

Commonwealth Equity Services, LLC

$66 Billion
Q3 2024

A detailed history of Commonwealth Equity Services, LLC transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Commonwealth Equity Services, LLC holds 108,734 shares of LXRX stock, worth $118,520. This represents 0.0% of its overall portfolio holdings.

Number of Shares

108,734

Previous 101,134 7.51%

Holding current value

$118,520

Previous $170,000 0.59%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	BUY	$1.51 - $2.39 $11,476 - $18,164	7,600 Added 7.51%	108,734 $171,000
Q2 2024 Jul 31, 2024	BUY	$1.54 - $2.28 $9,163 - $13,565	5,950 Added 6.25%	101,134 $170,000
Q1 2024 Apr 29, 2024	BUY	$1.3 - $3.58 $79,300 - $218,380	61,000 Added 178.45%	95,184 $228,000
Q4 2023 Feb 06, 2024	SELL	$1.0 - $1.53 $5,385 - $8,239	-5,385 Reduced 13.61%	34,184 $52,000
Q3 2023 Oct 23, 2023	BUY	$1.06 - $2.33 $25,864 - $56,852	24,400 Added 160.85%	39,569 $43,000
Q2 2023 Aug 10, 2023	BUY	$2.15 - $3.49 $2,365 - $3,839	1,100 Added 7.82%	15,169 $35,000
Q1 2023 May 11, 2023	SELL	$1.99 - $2.68 $20,696 - $27,872	-10,400 Reduced 42.5%	14,069 $34,000
Q4 2022 Feb 07, 2023	SELL	$1.8 - $2.56 $192 - $273	-107 Reduced 0.44%	24,469 $46,000
Q2 2022 Jul 19, 2022	BUY	$1.31 - $2.69 $13,493 - $27,707	10,300 Added 72.15%	24,576 $45,000
Q3 2021 Oct 29, 2021	BUY	$3.38 - $5.35 $361 - $572	107 Added 0.76%	14,276 $68,000
Q4 2020 Feb 11, 2021	BUY	$1.05 - $3.67 $14,877 - $52,000	14,169 New	14,169 $48,000
Q1 2020 May 11, 2020	SELL	$1.8 - $4.28 $29,629 - $70,453	-16,461 Closed	0 $0
Q3 2019 Oct 30, 2019	BUY	$1.2 - $6.66 $5,695 - $31,608	4,746 Added 40.51%	16,461 $49,000
Q2 2019 Jul 19, 2019	SELL	$5.35 - $7.11 $8,725 - $11,596	-1,631 Reduced 12.22%	11,715 $73,000
Q1 2019 May 13, 2019	SELL	$4.36 - $7.94 $35,629 - $64,885	-8,172 Reduced 37.98%	13,346 $74,000
Q4 2018 Feb 11, 2019	SELL	$6.15 - $10.51 $36,900 - $63,060	-6,000 Reduced 21.8%	21,518 $142,000
Q3 2018 Nov 06, 2018	BUY	$10.32 - $13.06 $2,094 - $2,651	203 Added 0.74%	27,518 $293,000
Q2 2018 Jul 31, 2018	BUY	$7.8 - $13.69 $20,280 - $35,594	2,600 Added 10.52%	27,315 $328,000
Q1 2018 May 14, 2018	BUY	$7.86 - $11.39 $16,781 - $24,317	2,135 Added 9.46%	24,715 $211,000
Q4 2017 Feb 12, 2018	BUY	$8.77 - $12.28 $198,026 - $277,282	22,580	22,580 $223,000

Others Institutions Holding LXRX

# of Institutions

137

Shares Held

242M

Call Options Held

617K

Put Options Held

286K

View Full List

About LEXICON PHARMACEUTICALS, INC.

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $206M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

More about LXRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.

Account

Commonwealth Equity Services, LLC Lexicon Pharmaceuticals, Inc. Transaction History